I don't disagree about the market potential in Europe, nor Europeans not being able shell out the money for good CBD. That's all well documented and a fact.
My opinion is strictly around that of POTN. They'll never break the barriers to entry within the European market, when they clearly haven't learned how to even walk here in the U.S.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.